l-365260 and Body-Weight

l-365260 has been researched along with Body-Weight* in 2 studies

Other Studies

2 other study(ies) available for l-365260 and Body-Weight

ArticleYear
Cholecystokinin inhibits food intake at a peripheral extragastric site.
    Annals of the New York Academy of Sciences, 1994, Mar-23, Volume: 713

    Topics: Anastomosis, Roux-en-Y; Animals; Benzodiazepinones; Body Weight; Cholecystokinin; Devazepide; Dose-Response Relationship, Drug; Fasting; Feeding Behavior; Gastrectomy; Phenylurea Compounds; Rats; Receptors, Cholecystokinin; Sincalide; Time Factors

1994
Type-A CCK receptors mediate the inhibition of food intake and activity by CCK-8 in 9- to 12-day-old rat pups.
    Pharmacology, biochemistry, and behavior, 1991, Volume: 38, Issue:1

    To determine the type of cholecystokinin (CCK) receptor that mediates the inhibitory effects of peripherally administered CCK-8 on food intake and activity in 9- to 12-day-old rat pups, we gave injections of a type-A CCK receptor antagonist, MK-329, or of the type-B CCK receptor antagonist, L-365,260, prior to CCK-8 (IP). MK-329 reversed the inhibitory effects of CCK-8, but L-365,260 did not. This demonstrates that the inhibitory effects of CCK-8 (IP) are mediated by type-A, but not type-B, CCK receptors in pups of this age.

    Topics: Animals; Benzodiazepinones; Body Weight; Cholecystokinin; Devazepide; Feeding Behavior; Female; Motor Activity; Phenylurea Compounds; Pregnancy; Rats; Rats, Inbred Strains; Receptors, Cholecystokinin

1991